Insider Shareholders with Direct Ownership of Olema Pharmaceuticals, Inc. (OLMA)
This section provides a comprehensive overview of the insiders with direct ownership of Olema Pharmaceuticals, Inc. (OLMA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Olema Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bvf Partners L P
Director |
8,797,617 | 0 | 2,906,659 $25.5 Million | 4 |
Jun 10, 2022
Added 1.4%
|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
1,725,406 | 0 | 1,725,406 $15.1 Million | 1 |
Nov 23, 2020
Added 20.76%
|
|
Peter J. Kushner
CHIEF SCIENTIFIC OFFICER |
502,392 | 0 | 1,431,672 $12.6 Million | 2 |
Nov 23, 2020
Added 8.33%
|
| 230,596 | 383,581 | 751,283 $6.6 Million | 36 |
Jul 30, 2024
Reduced 0.12%
|
|
|
David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF |
169,722 | 54,370 | 574,099 $5.04 Million | 10 |
Nov 22, 2023
Reduced 1.15%
|
|
Shane William Charles Kovacs
Ch. Operating & Financial Off. |
510,430 | 18,742 | 510,458 $4.48 Million | 9 |
Nov 15, 2024
Added 4.67%
|
|
Frank Mccormick
Director |
152,891 | 0 | 191,113 $1.68 Million | 1 |
Nov 23, 2020
Added 44.44%
|
|
Sean Bohen
PRESIDENT AND CEO |
191,899 | 67,225 | 144,925 $1.27 Million | 15 |
Nov 22, 2023
Reduced 16.16%
|
|
Naseem Zojwalla
CHIEF MEDICAL OFFICER |
87,160 | 14,556 | 89,824 $788,654 | 8 |
May 24, 2024
Added 9.53%
|
| 83,876 | 0 | 83,876 $736,431 | 1 |
Sep 16, 2020
Added 50.0%
|
|
|
Kinney Horn
Chief Business Officer |
132,692 | 132,692 | 2,458 $21,581 | 22 |
Mar 10, 2022
Reduced 68.12%
|